Alumni of UC Berkeley (Graduate)
Velox Biosystems, a clinical diagnostics startup out of UC Irvine, is committed to applying their innovative detection technology to develop rapid, cost effective, and highly accurate tests and instruments to combat the rise in antimicrobial resistance (AMR). Velox is currently developing a point-of-care rapid screening and phenotypic antibiotic susceptibility test in order to significantly improve the diagnostic accuracy of urinary tract infection (UTI) screening and enable physicians to make objective antibiotic treatment decisions, thereby combating the vicious cycle of increasing AMR in UTI.
Primary Industry Sector: Medical Diagnostics
Funding Status: Seed